Ashley Mansell

Ashley Mansell

Company: Adiso Therapeutics

Job title: Head of Translational Sciences


Panel Discussion: Underpinning the Current Leading Challenges & Gaps in Inflammasome Therapeutic Research 10:00 am

Availability of appropriate animal models and patient samples Understanding progress and limitations to current biomarkers Movement into clinical trials and regulatory conversations How/Should we locally target inflammasomes at the sites of inflammation ? Dual/multi- inflammasome inhibition – specificity vs multifactorial inflammation in disease? How to dose a known pharmacological effect/target engagement to specific organs without…Read more

day: Day One

ADS032: a Novel Dual NLRP1 & NLRP3 Inhibitor to Target Inflammasome Inflammation 11:30 am

Learn about ADS032, a novel dual inflammasome inhibitor Discover how ADS032 reduces inflammation both in vitro and in vivo Evaluate how ADS032 reduces the inflammatory burden during inflammasome-related diseaseRead more

day: Day 2 - Track B - Morning

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.